<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>immune response enhancement &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/immune-response-enhancement/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 24 Oct 2025 14:06:50 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>immune response enhancement &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Nanoparticles: Harnessing Non-Covalent Epitopes Assembly</title>
		<link>https://bioengineer.org/nanoparticles-harnessing-non-covalent-epitopes-assembly/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 24 Oct 2025 14:06:42 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomedical nanotechnology applications]]></category>
		<category><![CDATA[immune response enhancement]]></category>
		<category><![CDATA[multiepitope nanoparticles]]></category>
		<category><![CDATA[nanoparticle vaccine development]]></category>
		<category><![CDATA[non-covalent epitope assembly]]></category>
		<guid isPermaLink="false">https://bioengineer.org/nanoparticles-harnessing-non-covalent-epitopes-assembly/</guid>

					<description><![CDATA[In a groundbreaking study, researchers have unveiled a novel technique that enhances the immunogenic potential of nanoparticles by facilitating the non-covalent assembly of multiple epitopes onto a single nanoparticle. This approach opens new avenues for vaccine development, particularly in eliciting robust immune responses against a variety of pathogens. The key to this advancement lies in [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">286318</post-id>	</item>
		<item>
		<title>Boosting Immune Responses via Proximity Labeling</title>
		<link>https://bioengineer.org/boosting-immune-responses-via-proximity-labeling/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 10 Sep 2025 22:52:37 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[antigen-induced receptor clustering]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[immune response enhancement]]></category>
		<category><![CDATA[proximity labeling technology]]></category>
		<category><![CDATA[synthetic antigen clustering]]></category>
		<guid isPermaLink="false">https://bioengineer.org/boosting-immune-responses-via-proximity-labeling/</guid>

					<description><![CDATA[In the rapidly evolving landscape of immunotherapy and cellular signaling, manipulating receptor dynamics on cell surfaces stands as a transformative approach to enhance immune responses. Recent breakthroughs have capitalized on the concept of antigen-induced receptor clustering, which serves as a pivotal trigger for cell signaling cascades. These clusters ordinarily form when receptors such as T [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">268551</post-id>	</item>
		<item>
		<title>AI-Driven Protein Design Advances T-Cell Immunotherapy Breakthroughs</title>
		<link>https://bioengineer.org/ai-driven-protein-design-advances-t-cell-immunotherapy-breakthroughs/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 01 Aug 2025 21:15:21 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[AI-driven protein design]]></category>
		<category><![CDATA[immune response enhancement]]></category>
		<category><![CDATA[Notch signaling pathway activation]]></category>
		<category><![CDATA[synthetic ligand development]]></category>
		<category><![CDATA[T-cell immunotherapy advancements]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ai-driven-protein-design-advances-t-cell-immunotherapy-breakthroughs/</guid>

					<description><![CDATA[In a groundbreaking advancement published in the prestigious journal Cell, scientists have unveiled a revolutionary synthetic ligand capable of activating the Notch signaling pathway, a critical regulator in T-cell development and immune function. This pioneering work harnesses state-of-the-art AI-driven computational protein design to engineer soluble Notch agonists that can be applied to optimize clinical T-cell [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">252535</post-id>	</item>
	</channel>
</rss>
